参考文献/References:
[1] 《中国心血管健康与疾病报告2021》编写组.《中国心血管健康与疾病报告2021》概述[J].中国心血管病研究,2022,20(7):577-596.
[2] Kivim?ki M,Steptoe A.Effects of stress on the development and progression of cardiovascular disease[J].Nat Rev Cardiol,2018,15(4):215-229.
[3] 琚敏,汪蕾,宋雷,等.心脏交感神经显像的临床应用和研究进展[J].心血管病学进展,2023,44(1):16-20.
[4] 李甲坤,郑黎晖.心脏交感神经活动评估方法的研究进展[J].中国心血管病研究,2021,19(9):797-801.
[5] Qin R,Murakoshi N,Xu D,et al.Exercise training reduces ventricular arrhythmias through restoring calcium handling and sympathetic tone in myocardial infarction mice[J].Physiol Rep,2019,7(4):e13972.
[6] Rey-garcía J,Townsend RR.Renal denervation:a review[J].Am J Kidney Dis,2022,80(4):527-535.
[7] Kora?evi? G,Zdravkovi? M.What is stress hyperglycemia? A suggestion for an improvement of its definition[J].Acta Endocrinol(Buchar),2021,17(4):548-551.
[8] 张瑞.应激性高血糖与急性心肌梗死患者短期预后的相关性研究[D].山东:山东大学,2016[2022-08-03].
[9] Rajpurohit A,Sejoo B,Bhati R,et al.Association of stress hyperglycemia and adverse cardiac events in acute myocardial infarction - a cohort study[J].Cardiovasc Hematol Disord Drug Targets,2021,21(4):260-265.
[10] Cui K,Fu R,Yang J,et al.Admission blood glucose and 2-year mortality after acute myocardial infarction in patients with different glucose metabolism status:a prospective,nationwide,and multicenter registry[J].Front Endocrinol (Lausanne),2022,13:898384.
[11] Cui C,Zhou M,Cheng L,et al.Admission hyperglycemia as an independent predictor of long-term prognosis in acute myocardial infarction patients without diabetes:a retrospective study[J] .J Diabetes Investig,2021,12(7):1244-1251.
[12] Gao S,Liu Q,Chen H,et al.Predictive value of stress hyperglycemia ratio for the occurrence of acute kidney injury in acute?myocardial infarction patients with diabetes[J].BMC Cardiovasc Disord,2021,21(1):157.
[13] Cui K,Fu R,Yang J,et al.Stress hyperglycemia ratio and long-term mortality after acute myocardial infarction in patients with and without diabetes:a prospective ,nationwide,and multicentre registry[J].Diabetes Metab Res Rev,2022,38(7):e3562.
[14] Fu R,Cui K,Yang J,et al.Fasting stress hyperglycemia ratio and in-hospital mortality after acute myocardial infarction in patients with different glucose metabolism status:results from China acute myocardial infarction registry[J].Diabetes Res Clin Pract,2023,196:110241.
[15] 齐疏影,李响,刘飞.血糖间隙对非糖尿病急性ST段抬高型心肌梗死患者发生心肌缺血再灌注损伤的预测价值[J].中华危重症医学杂志(电子版),2021,14(6):448-452.
[16] Zhu Y,Liu K,Meng S,et al.Augmented glycaemic gap is a marker for an increased risk of post-infarct left ventricular systolic dysfunction[J].Cardiovasc Diabetol,2020,19(1):101.
[17] Ostrowski SR,Pedersen SH,Jensen JS,et al.Acute myocardial infarction is associated with endothelial glycocalyx and cell damage and a parallel increase in circulating catecholamines[J].Crit Care,2013,17(1):R32.
[18] Cuculi F,Herring N,de Caterina AR,et al.Relationship of plasma neuropeptide Y with angiographic,electrocardiographic and coronary physiology indices of reperfusion during ST elevation myocardial infarction[J].Heart,2013,99(16):1198-1203.
[19] Herring N,Tapoulal N,Kalla M,et al.Neuropeptide-Y causes coronary microvascular constriction and is associated with reduced ejection fraction following ST-elevation myocardial infarction[J].Eur Heart J,2019,40(24):1920-1929.
[20] Gibbs T,Tapoulal N,Shanmuganathan M,et al.Neuropeptide-Y levels in st-segment-elevation myocardial infarction:relationship with coronary microvascular function,heart failure,and mortality[J].J Am Heart Assoc,2022,11(13):e024850.
[21] Kalla M,Hao G,Tapoulal N,et al.The cardiac sympathetic co-transmitter neuropeptide Y is pro-arrhythmic following ST-elevation myocardial infarction despite beta-blockade[J].Eur Heart J,2020,41(23):2168-2179.
[22] Estensen ME,Hognestad A,Syversen U,et al.Prognostic value of plasma chromogranin A levels in patients with complicated myocardial infarction[J].Am Heart J,2006,152(5):927.e1-e6.
[23] Iso T,Sunaga H,Matsui H,et al.Serum levels of fatty acid binding protein 4 and fat metabolic markers in relation to catecholamines following exercise[J].Clin Biochem,2017,50(16-17):896-902.
[24] 王钻锦,傅乙柳,张小燕,等.血清脂肪酸结合蛋白4水平与急性心肌梗死患者冠状动脉病变程度及预后相关性[J].临床军医杂志,2022,50(6):567-569,572.
[25] Shen YS,Chan CM,Chen WL,et al.Initial salivary α-amylase activity predicts malignant ventricular arrhythmias and short-term prognosis after ST-segment elevation myocardial infarction[J].Emerg Med J,2011,28(12):1041-1045.
[26] Shen YS,Chen WL,Chang HY,et al.Diagnostic performance of initial salivary alpha-amylase activity for acute myocardial infarction in patients with acute chest pain[J].J Emerg Med,2012,43(4):553-560.
相似文献/References:
[1]林远龙,刘现亮.无复流现象:从基础到临床[J].心血管病学进展,2016,(1):53.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.014]
LIN Yuanlong,LIU Xianliang.From Bench to Bed:No-reflow Phenomenon[J].Advances in Cardiovascular Diseases,2016,(10):53.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.014]
[2]赵劲东,综述,董平栓,等.合并多支血管病变的急性ST段抬高型心肌梗死介入术治疗策略的研究进展[J].心血管病学进展,2016,(3):295.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.021]
ZHAO Jindong,DONG Pingshuan.Research Progress of Interventional Therapy in Patients with ST-elevation
Myocardial Infarction and Multivessel Disease[J].Advances in Cardiovascular Diseases,2016,(10):295.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.021]
[3]余正春,综述,马小静,等.急性心肌梗死并发心源性休克的治疗进展[J].心血管病学进展,2016,(4):441.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.029]
YU Zhengchun,MA Xiaojing.Treatment of Cardiogenic Shock Complicating Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2016,(10):441.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.029]
[4]袁帅,毛玉琳,钱志敏,等.经皮冠脉介入术在高龄老年患者治疗中的研究新进展[J].心血管病学进展,2019,(6):864.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.007]
YUAN Shuai,MAO Yulin,QIAN Zhimin,et al.New Progress in Study of PCI in treatment of Elderly Patients[J].Advances in Cardiovascular Diseases,2019,(10):864.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.007]
[5]元洋洋 李波.Selvester QRS评分系统研究进展[J].心血管病学进展,2019,(7):985.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.005]
YUAN YangyangLI Bo.Research Progress of Selvester QRS Scoring System[J].Advances in Cardiovascular Diseases,2019,(10):985.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.005]
[6]翁子骞 于波.血栓抽吸在急性ST段抬高型心肌梗死中的研究进展[J].心血管病学进展,2019,(7):1035.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.018]
WENG ZiqianYU Bo.Thrombus aspiration in acute ST-segment elevation myocardial infarction[J].Advances in Cardiovascular Diseases,2019,(10):1035.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.018]
[7]林莉 韦铁民.急性心肌梗死后心脏破裂[J].心血管病学进展,2019,(7):1039.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.019]
LIN LiWEI Tiemin.Post-infarction Cardiac Rupture[J].Advances in Cardiovascular Diseases,2019,(10):1039.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.019]
[8]杨颜瑜,苏星,谭敏,等.炎症指标与急性心肌梗死研究进展[J].心血管病学进展,2019,(6):947.[doi:10.16806/j.cnki.issn.1004-3934.2019.0.027]
YANG Yanyu,SU Xing,TAN Min,et al.Relationship Between Inflammation Index and Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(10):947.[doi:10.16806/j.cnki.issn.1004-3934.2019.0.027]
[9]崔小豪 杨志明.和肽素在急性心肌梗死中的研究进展[J].心血管病学进展,2019,(5):726.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.016]
CUI Xiaohao,YANG Zhiming.Copeptin in Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(10):726.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.016]
[10]潘甜 马康华.急性心肌梗死经皮冠脉介入术后冠状动脉无复流的预防和治疗进展[J].心血管病学进展,2019,(5):730.[doi:10.16806/j.cnki.issn.1004-3932019.05.017]
PAN Tian,MA Kanghua.Prevention and Treatment of Coronary Artery No-Reflow after Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(10):730.[doi:10.16806/j.cnki.issn.1004-3932019.05.017]